RxDoctor Payments Data

Sameet Sohi, MD

Otolaryngology · Louisville, KYNPI 1154507903

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.9% of the total across 152 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by Optinose US, Inc. at 28.5% of the total.

$3,260in general payments, 2019–2025

Across 152 payments — averaging $21.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$931
  • GSK$387
  • Regeneron Healthcare Solutions, Inc.$287
  • Sanofi$284
  • Stryker$244
  • Intersect ENT, Inc.$149
  • plus $978 from 21 others

What the payments were for

  • Consulting fees$1003%
  • Food & beverage$3,12696%
  • Education$341%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,260 in reported general payments places this provider in the 75th percentile of 137 otolaryngology providers in Kentucky.

See all otolaryngology providers in Kentucky

Medicare billing

Part B allowed, 2024
$206,550
Medicare patients
489
Services billed
2,600

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide140$4,988
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth15$1,411
Mometasone Furoate23$717
Levocetirizine Dihydrochloride41$507
Hydroxyzine Hcl45$445
Albuterol Sulfate HfaAlbuterol Sulfate13$438
Fluticasone Propionate38$405
Fluocinolone Acetonide Oil13$326
Lidocaine Hcl ViscousLidocaine Hcl14$319
Methylprednisolone48$316
Montelukast Sodium33$297
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav36$270
Fluconazole16$213
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen25$202
Amitriptyline Hcl23$188

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →